• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Exopharm

Exopharm

  • Home
  • Products
  • Partnering
  • Science
  • Resources
    • ASX Announcements
    • Investor Information
    • News & Articles
    • Careers
  • About Us
    • Our Values
    • Our Story
    • Our Team
    • Board of Directors
  • Contact

Products

Engineered EVs

Engineered EVs (EEVs) are an emerging form of precision medicine with immense promise and application in key areas such as neurology, cardiology and oncology. EEVs can be directed to certain cell types and carry powerful cargos, such as RNA, enzymes and/or small molecules. Because of their cellular provenance, EEVs avoid critical limitations of other delivery vehicles such as liposomes and other synthetic nanoparticles. Exopharm has a number of EEV projects under development including Fortrexo for combating viral infections and Cognevo for the delivery of drugs to the central nervous system.

 

 

Exopharm’s EVPS technology was in-licensed in 2020 from Santa Clara University USA and enables the addition of custom surface proteins to EVs for targeting to specific tissues. Our LOAD technology, in-licensed from the State University of New York at Buffalo USA, enables us to load EVs with specialised therapeutic cargo.

Product Pipeline

 

Footer

Resources

  • ASX Announcements
  • Investor Information
  • Board of Directors
  • News & Articles

Information

  • Contact
  • Partnering
  • Join Our Mailing List
  • Privacy, Terms and Conditions
  • Facebook
  • LinkedIn
  • Twitter
  • Vimeo
Copyright © 2021 · Exopharm · ACN 163 765 991 · info@exopharm.com
Level 17/31 Queen St, Melbourne VIC Australia 3000 · P: +61 (0)3 9111 0026 ·

Web Design by Mallee Blue Media